...
首页> 外文期刊>Current pharmaceutical design >D-Cycloserine as an Augmentation Strategy for Cognitive Behavioral Therapy for Anxiety Disorders: An Update
【24h】

D-Cycloserine as an Augmentation Strategy for Cognitive Behavioral Therapy for Anxiety Disorders: An Update

机译:D-环丝氨酸作为一种焦虑症认知行为疗法的增强策略:更新

获取原文
获取原文并翻译 | 示例

摘要

Cognitive behavioral therapy (CBT) has been shown to be an effective intervention for anxiety disorders. However, despite its proven efficacy, some patients fail to respond to an adequate course of treatment. In attempts to improve the efficacy of CBT, researchers have augmented the core learning processes of the intervention with d-cycloserine (DCS), an N-Methyl-D-Aspartate partial agonist. This article reviews the current literature on DCS as an augmentation strategy for CBT for anxiety disorders. We will describe the memory enhancing properties of DCS, review findings from randomized controlled studies of DCS in anxious populations and discuss mechanism, dosing and timing issues.
机译:认知行为疗法(CBT)已被证明是焦虑症的有效干预措施。然而,尽管已证明其疗效,但仍有一些患者对适当的疗程无反应。为了提高CBT的疗效,研究人员通过N-甲基-D-天冬氨酸部分激动剂d-环丝氨酸(DCS)扩大了干预的核心学习过程。本文回顾了有关DCS作为焦虑症CBT增强策略的最新文献。我们将描述DCS的记忆增强特性,回顾焦虑人群中DCS的随机对照研究结果,并讨论机理,剂量和时间安排问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号